+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 46975

Chapter 46975 contains a list of PDF Full Texts available from EurekaMag.





Matyja, E.; Taraszewska, A.; Zabek, M., 2001:
Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study

Matyja, E.; Taraszewska, A.; Nagańska, E.; Zabek, M., 2001:
Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study

Eremin, V.F., 1998:
Phenotypic characteristics of HIV isolates, isolated in the Belarus Republic

Ageeva, S.N.; Kondrat'eva, T.F.; Karavaĭko, G.E., 2001:
Phenotypic characteristics of Thiobacillus ferrooxidans strains

Yumura-Yagi, K.; Hara, J.; Tawa, A.; Kawa-Ha, K., 1994:
Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis

Doria, A.; Yang, Y.; Malecki, M.; Scotti, S.; Dreyfus, J.; O'Keeffe, C.; Orban, T.; Warram, J.H.; Krolewski, A.S., 1999:
Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes

Grisar, J.; Hahn, P.; Brosch, S.; Peterlik, M.; Smolen, J.S.; Pietschmann, P., 2001:
Phenotypic characteristics of human monocytes undergoing transendothelial migration

Yang, L.; Li, X.; Zheng, X., 2002:
Phenotypic characteristics of infiltrated inflammatory cells, renal tubular epithelial cells and interstitial cells and their possible roles in the outcome of human drug-associated interstitial nephritis

Gaenko, G.P.; Kozlov, A.M.; Saprykina, N.S.; Dorotnikova, E.B.; Khaidukov, S.V.; Molotkovskii, Y.G., 2003:
Phenotypic characteristics of lewis lung carcinoma cells

Kullander, S..; Rausing, A.., 1994:
Phenotypic characteristics of mononuclear cells in human ovarian tumors - with special reference to cystic and ascitic fluid

Nikulina, S.Iu.; Shulman, V.A.; Nikolaev, V.G.; Puzyrev, V.P.; Ivanitskaia, I.V.; Matiushin, G.V., 2002:
Phenotypic characteristics of patients with primary disorders of cardiac conduction

Javier Castillo, F.; Larraz, V.; Asunción Lafarga, M.; Navarro, M.; Gómez-Lus, R., 1994:
Phenotypic characterization and distribution of Yersinia in human and environmental samples

Dzhanga, A.A.; Barabanshchikov, B.I.; Malkov, S.V., 1997:
Phenotypic characterization of Bacillus subtilis mutants with decreased exonuclease I activity

Galéa, P.; Brezinschek, R.; Lipsky, P.E.; Oppenheimer-Marks, N., 1994:
Phenotypic characterization of CD4-/alpha beta TCR+ and gamma delta TCR+ T cells with a transendothelial migratory capacity

Sereno, D.; Michon, P.; Brajon, N.; Lemesre, J.L., 1998:
Phenotypic characterization of Leishmania mexicana pentamidine-resistant promastigotes. Modulation of the resistance during in-vitro developmental life cycle

Maia, M.L.; Dos Santos, J.I.; Viani, F.C.; Larsson, C.E.; Paula, C.R.; Gambale, W., 2002:
Phenotypic characterization of Microsporum canis isolated from cats and dogs

Rantamäki, L.K.; Müller, H.P., 1995 :
Phenotypic characterization of Streptococcus dysgalactiae isolates from bovine mastitis by their binding to host derived proteins

Dos Santos, J.I.; Vicente, E.J.; Paula, C.R.; Gambale, W., 2002:
Phenotypic characterization of Trichophyton rubrum isolates from two geographic locations in Brazil

Mohan, K.; Sadza, M.; Madsen, M.; Hill, F.W.; Pawandiwa, A., 1994:
Phenotypic characterization of Zimbabwean isolates of Pasteurella multocida

Ross, S.A.; Wong, J.Y.; Clifford, J.J.; Kinsella, A.; Massalas, J.S.; Horne, M.K.; Scheffer, I.E.; Kola, I.; Waddington, J.L.; Berkovic, S.F.; Drago, J., 2000:
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse

Ivanova, S.A.; Shekhonin, B.V.; Chumakov, A.A., 1997:
Phenotypic characterization of cells and structure of the extracellular matrix in pleomorphic adenoma of the salivary glands

Limia, A.; Jiménez, M.L.; Delgado, T.; Sánchez, I.; López, S.; López-Brea, M., 1998:
Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens

Fournier, D.; Mouton, C., 1993:
Phenotypic characterization of human and animal biotypes within the species Porphyromonas gingivalis

Belvedere, O.; Feruglio, C.; Malangone, W.; Bonora, M.L.; Donini, A.; Dorotea, L.; Tonutti, E.; Rinaldi, C.; Pittino, M.; Baccarani, M.; Del Frate, G.; Biffoni, F.; Sala, P.; Hilbert, D.M.; Degrassi, A., 1999:
Phenotypic characterization of immunomagnetically purified umbilical cord blood CD34+ cells

Torun, T.; Sezgin, N.; Savas, L.; Yalcin, F., 2002:
Phenotypic characterization of infiltrates in dilated cardiomyopathy--diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy

Talarico, G.M.; Neiders, M.E.; Comeau, R.L.; Cohen, R.E., 1997:
Phenotypic characterization of mononuclear cells from gingiva associated with periodontitis and peri-implantitis

Macedo, A.; Orfao, A.; Ciudad, J.; San Miguel, J.F., 1994:
Phenotypic characterization of normal myeloid differentiation

Rodríguez-Carreño, M.P.; López-Fuertes, L.; Revilla, C.; Ezquerra, A.; Alonso, F.; Domínguez, J., 2001:
Phenotypic characterization of porcine IFN-gamma-producing lymphocytes by flow cytometry

Băncescu, G.; Dumitriu, S.; Băncescu, A.; Skaug, N., 2002:
Phenotypic characterization of some anginosus group isolates from oral and maxillofacial infections

Jones, D.; Dorfman, D.M., 2001:
Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma

Cohen-Tanugi, A.; Bolle, M.; Boy-Lefèvre, M.L.; Anagnostou, F.; Forest, N., 1996:
Phenotypic characterization of the 3/A/1D-1M osteogenic cell line derived from in vivo transplantation of 3/A/1D-1 chondroprogenitor murine teratocarcinoma cells

Li, L.S.; Lönnqvist, F.; Luthman, H.; Arner, P., 1996:
Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects

Maes, B.; Fryns, J.P.; Ghesquière, P.; Borghgraef, M., 2000:
Phenotypic checklist to screen for fragile X syndrome in people with mental retardation

Sinnecker, G.H.; Hiort, O.; Dibbelt, L.; Albers, N.; Dörr, H.G.; Hauss, H.; Heinrich, U.; Hemminghaus, M.; Hoepffner, W.; Holder, M.; Schnabel, D.; Kruse, K., 1996:
Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency

Kaneita, Y.; Yasukawa, K.; Kura, Y.; Yamazaki, T.; Sawada, U., 2000:
Phenotypic classification of malignant lymphoma

Forlino, A.; D'amato, E.; Valli, M.; Camera, G.; Hopkins, E.; Marini, J.C.; Cetta, G.; Coviello, D.A., 1998:
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation

Schallhammer, L.; Walcher, W.; Wintersteiger, R.; Dohr, G.; Sedlmayr, P., 1997:
Phenotypic comparison of natural killer cells from peripheral blood and from early pregnancy decidua

Culiat, C.T.; Stubbs, L.J.; Montgomery, C.S.; Russell, L.B.; Rinchik, E.M., 1994:
Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice

David, J.; Roux, M., 2000:
Phenotypic convergence among pentacrines Endoxocrinus and Diplocrinus related to environmental constraints

Gush, K.A.; Fu, K.L.; Grompe, M.; Walsh, C.E., 2000:
Phenotypic correction of Fanconi anemia group C knockout mice

Walsh, C.E.; Nienhuis, A.W.; Samulski, R.J.; Brown, M.G.; Miller, J.L.; Young, N.S.; Liu, J.M., 1994:
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector

Foster, P.A.; Varma, R.R., 1996:
Phenotypic correction of activated protein C resistance following orthotopic liver transplantation

Ejima, Y.; Sasaki, M.S., 1998:
Phenotypic correction of ataxia-telangiectasia cellular defect by exogenously introduced human or mouse subchromosomal fragments

Desai, U.J.; Slosberg, E.D.; Boettcher, B.R.; Caplan, S.L.; Fanelli, B.; Stephan, Z.; Gunther, V.J.; Kaleko, M.; Connelly, S., 2001:
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression

Hahn, T.M.; Copeland, K.C.; Woo, S.L., 1996:
Phenotypic correction of dwarfism by constitutive expression of growth hormone

Liu, G.; Ashbourne Excoffon, K.J.; Wilson, J.E.; McManus, B.M.; Rogers, Q.R.; Miao, L.; Kastelein, J.J.; Lewis, M.E.; Hayden, M.R., 2000:
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer

Tietge, U.J.; Sun, G.; Czarnecki, S.; Yu, Q.; Lohse, P.; Du, H.; Grabowski, G.A.; Glick, J.M.; Rader, D.J., 2001:
Phenotypic correction of lipid storage and growth arrest in wolman disease fibroblasts by gene transfer of lysosomal acid lipase

Hanenberg, H.; Batish, S.Dev.; Pollok, K.E.; Vieten, L.; Verlander, P.C.; Leurs, C.; Cooper, R.J.; Göttsche, K.; Haneline, L.; Clapp, D.Wade.; Lobitz, S.; Williams, D.A.; Auerbach, A.D., 2002:
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool

Leppig, K.A.; Pagon, R.A., 1993:
Phenotypic correlations of ocular coloboma without known cause

Drysdale, R., 2001:
Phenotypic data in FlyBase

Chuong, C.M.; Noveen, A., 2000:
Phenotypic determination of epithelial appendages: genes, developmental pathways, and evolution

Shiraiwa, H.; Nishijima, Y.; Akaza, H.; Uchida, K.; Kawai, K.; Sasaki, A.; Hattori, K.; Miyanaga, N.; Koiso, K., 1993:
Phenotypic difference of lymphocytes circulating in tumorous renal artery and renal vein in patients with renal cell carcinoma

Allen, R.W.; Pritchard, J.; Harmon, J.; Floyd, S., 2000:
Phenotypic differences at the HUMvWA locus amplified with different STR kits

Fujii, T.; Hattori, H.; Higuchi, Y.; Tsuji, M.; Mitsuyoshi, I., 1998:
Phenotypic differences between T-->C and T-->G mutations at nt 8993 of mitochondrial DNA in Leigh syndrome

Chipev, C.C.; Simon, M., 2002:
Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1

Koch, L.G.; Britton, S.L.; Barbato, J.C.; Rodenbaugh, D.W.; DiCarlo, S.E., 2000:
Phenotypic differences in cardiovascular regulation in inbred rat models of aerobic capacity

van Beuningen, H.M.; Stoop, R.; Buma, P.; Takahashi, N.; van der Kraan, P.M.; van den Berg, W.B., 2002:
Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage

Korytko, A.I.; Vessey, S.H.; Blank, J.L., 1999:
Phenotypic differences in the GnRH neuronal system of deer mice Peromyscus maniculatus under a natural short photoperiod

Boye, C.S.; Diop, A.; Kaire, O.; Ndoye, I.; Moreau, J.C.; Niang, N.S.; Diadhiou, F.; Mboup, S., 1996:
Phenotypic differences of nosocomial bacterial strains isolated in the obstetric-gynecology service of the University Hospital Center of Dakar

Hall, F.L.; Han, B.; Kundu, R.K.; Yee, A.; Nimni, M.E.; Gordon, E.M., 2001:
Phenotypic differentiation of TGF-beta1-responsive pluripotent premesenchymal prehematopoietic progenitor (P4 stem) cells from murine bone marrow

McVeigh, R.R.; Yasbin, R.E., 1996:
Phenotypic differentiation of "smart" versus "naive" bacteriophages of Bacillus subtilis

Hudgins, L.; Geer, J.S.; Cassidy, S.B., 2001:
Phenotypic differerencss in African Americans with Prader-Willi syndrome

Kravchenko, V.V.; Medvinskii, A.B.; Ivanitskii, G.R., 2001:
Phenotypic dissociation in an Escherichia coli population

Amat, J.A.; Ishiguro, H.; Nakamura, K.; Norton, W.T., 1996:
Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds

Istomin, A.V., 1994:
Phenotypic diversity in continuous and discrete populations exemplified by the bank vole under the conditions of the southern taiga

Seller, M.J.; Flinter, F.A.; Docherty, Z.; Fagg, N.; Newbould, M., 1997:
Phenotypic diversity in the Smith-Lemli-Opitz syndrome

Said-Nahal, R.; Miceli-Richard, C.; D'Agostino, M.A.; Dernis-Labous, E.; Berthelot, J.M.; Duché, A.; Le Blévec, G.; Saraux, A.; Perdriger, A.; Guis, S.; Amor, B.; Dougados, M.; Breban, M., 2002:
Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy

Niewiarowski, P.H.; Balk, M.L.; Londraville, R.L., 1999:
Phenotypic effects of leptin in an ectotherm: a new tool to study the evolution of life histories and endothermy?

Gómez Gerique, J.A.; López Martínez, D.; Cancelas, P.; Montoya, M.T.; Gutiérrez, M.D.; Porres, A., 2000:
Phenotypic expression of Lp(a) in Spanish children and adolescents

Kreneva, R.A.; Gusarov, I.I.; Kozlov, I.I.; Perumov, D.A., 1997:
Phenotypic expression of a 100-pair nucleotide deletion in the regulatory region of the Bacillus subtilis riboflavin operon

Lindskog, S.; Ahlman, H.; Illerskog, A.; Nilsson, O.; Nilsson, B.; Tisell, L.E.; Ysander, L.; Jansson, S., 2001:
Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden

Winslow, J.T.; Young, L.J.; Hearn, E.; Gingrich, B.; Wang, Z.; Guo, Q.; Matzuk, M.M.; Insel, T.R., 1999:
Phenotypic expression of an oxytocin peptide null mutation in mice

Ekström, U.; Ponjavic, V.; Abrahamson, M.; Nilsson-Ehle, P.; Andrëasson, S.; Stenström, I.; Ehinger, B., 1998:
Phenotypic expression of autosomal dominant retinitis pigmentosa in a Swedish family expressing a Phe-211-Leu variant of peripherin/RDS

Vialettes, B.H.; Paquis-Flucklinger, V.; Pelissier, J.F.; Bendahan, D.; Narbonne, H.; Silvestre-Aillaud, P.; Montfort, M.F.; Righini-Chossegros, M.; Pouget, J.; Cozzone, P.J.; Desnuelle, C., 1997:
Phenotypic expression of diabetes secondary to a T14709C mutation of mitochondrial DNA. Comparison with MIDD syndrome (A3243G mutation): a case report

Yao, T.; Takata, M.; Tustsumi, S.; Nishiyama, K-ichi.; Taguchi, K-ichi.; Nagai, E.; Tsuneyoshi, M., 2003:
Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis

Ausems, M.G.; ten Berg, K.; Beemer, F.A.; Wokke, J.H., 2000:
Phenotypic expression of late-onset glycogen storage disease type II: identification of asymptomatic adults through family studies and review of reported families

Fried, A.; Shamay, A.; Wientroub, S.; Benayahu, D., 1996:
Phenotypic expression of marrow cells when grown on various substrata

Young, D.M.; Kok, R.G.; Ornston, L.Nicholas., 2002:
Phenotypic expression of polymerase chain reaction-generated random mutations in a foreign gene after its introduction into an Acinetobacter chromosome by natural transformation

Moodie, S.J.; Maxwell, J.D., 2001:
Phenotypic expression of the HFE gene mutation (C282Y) among the hospitalised population

Kiryu, K.; Morita, H.; Fujita, Y.; Kawasumi, M.; Shinzato, T.; Tsuruta, Y.; Nakai, S.; Maeda, K., 1994:
Phenotypic expressions of type I, III, IV, V, and VI collagens in patients with diabetic nephropathy: immunohistochemical comparison between HD and non-HD patients

Zhang, D.; Huang, Z.; Yang, H.; Cao, W.; Duan, J., 2003:
Phenotypic features and genetic diversity of strains of Rhodopseudomonas

Catena, E.; Mazzarella, G.; Peluso, G.F.; Micheli, P.; Cammarata, A.; Marsico, S.A., 1993:
Phenotypic features and secretory pattern of alveolar macrophages in atopic asthmatic patients

Pivovarova, T.A.; Kondrat'eva, T.F.; Batrakov, S.G.; Esipov, S.E.; Sheĭchenko, V.I.; Bykova, S.A.; Lysenko, A.M.; Karavaĭko, G.I., 2003:
Phenotypic features of Ferroplasma acidiphilum strains Yt and Y-2

Penovici, M.; Zachoval, R.; Schauer, R.; Rau, H.G.; Roth, U.; Hiller, E., 2002:
Phenotypic healing of factor II deficiency by liver transplantation

Simon, E.S., 1997:
Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for alpha 1 and beta glycine receptor subunits

Miller, W.L., 1997:
Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Yamamoto, M.; Sobue, G.; Yasuda, T.; Yamamoto, K.; Kumazawa, K.; Mitsuma, T., 1995:
Phenotypic heterogeneity in Japanese Charcot-Marie-Tooth disease type 1A patients with PMP-22 gene duplication

Thajeb, P.; Lee, H.C.; Pang, C.Y.; Jeng, C.M.; Huang, S.F.; Wei, Y.H., 2000:
Phenotypic heterogeneity in a Chinese family with mitochondrial disease and A3243G mutation of mitochondrial DNA

Nomura, K.; Umeki, K.; Hatayama, I.; Kuronuma, T., 2001:
Phenotypic heterogeneity in bullous congenital ichthyosiform erythroderma: possible somatic mosaicism for keratin gene mutation in the mildly affected mother of the proband

Arai, T.; Ikeda, K., 2001:
Phenotypic heterogeneity of FTDP-17: implications for the differences of pathological phenotype among sporadic tauopathies

Rutella, S.; Rumi, C.; Lucia, M.B.; Cauda, R.; Leone, G., 1997:
Phenotypic heterogeneity of PHA-activated CD69+ lymphocytes: the expression of APO-1/FAS antigen (CD95) and perforins identifies different functional subsets

Biernat, W.; Kordek, R.; Woźniak, L., 1996:
Phenotypic heterogeneity of nodular hidradenoma. Immunohistochemical analysis with emphasis on cytokeratin expression

Castaman, G.; Lunghi, B.; Missiaglia, E.; Bernardi, F.; Rodeghiero, F., 1997:
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V

Sanyal, S.; Basole, A.; Krishnan, K.S., 1999:
Phenotypic interaction between temperature-sensitive paralytic mutants comatose and paralytic suggests a role for N-ethylmaleimide-sensitive fusion factor in synaptic vesicle cycling in Drosophila

Riddle, J.E.; Cheema, A.; Sobesky, W.E.; Gardner, S.C.; Taylor, A.K.; Pennington, B.F.; Hagerman, R.J., 1998:
Phenotypic involvement in females with the FMR1 gene mutation

Yang, A.G.; Bai, X.; Huang, X.F.; Yao, C.; Chen, S., 1997:
Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection

Mariotti, C.; Castellotti, B.; Pareyson, D.; Testa, D.; Eoli, M.; Antozzi, C.; Silani, V.; Marconi, R.; Tezzon, F.; Siciliano, G.; Marchini, C.; Gellera, C.; Donato, S.D., 2000:
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families

Mittwoch, U., 1998:
Phenotypic manifestations during the development of the dominant and default gonads in mammals and birds

Dupré, N.; Bouchard, J.P.; Cossette, L.; Brunet, D.; Vanasse, M.; Lemieux, B.; Mathon, G.; Puymirat, J., 1999:
Phenotypic manifestations in French-Canadian populations with Charcot-Marie-Tooth disease type 1A associated with 17p11.2 duplication

Murphy, L.J.; Rajkumar, K.; Molnar, P., 1995:
Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice

Ross, J.A.; Ansell, I.; Hjelle, J.T.; Anderson, J.D.; Miller-Hjelle, M.A.; Dobbie, J.W., 2000:
Phenotypic mapping of human mesothelial cells

Davidson, N.J.; Boyd, R.L., 1993:
Phenotypic mapping of the chicken embryonic thymic microenvironment developing within an organ culture system

Danova, M.; Girino, M.; Riccardi, A., 2001:
Phenotypic markers in colorectal cancer

Montes, G.S.; Zugaib, M.; Joazeiro, P.P.; Varayoud, J.; Ramos, J.G.; Muñoz-de-Toro, M.; Luque, E.H., 2003:
Phenotypic modulation of fibroblastic cells in the mucous layer of the human uterine cervix at term

Han, Y.S.; Ueda, M.; Tanabe, S.; Nakatani, T.; Kishimoto, T.; Nagai, R., 2000:
Phenotypic modulation of neointimal smooth muscle cells during the evolution of transplant renal arteriosclerosis determined via myosin heavy chain expression

Malemud, C.J.; Papay, R.S.; Hering, T.M.; Holderbaum, D.; Goldberg, V.M.; Haqqi, T.M., 1995:
Phenotypic modulation of newly synthesized proteoglycans in human cartilage and chondrocytes

Kanda, K.; Matsuda, T.; Miwa, H.; Oka, T., 1993:
Phenotypic modulation of smooth muscle cells in intima-media incorporated hybrid vascular prostheses

Nagai, R.; Suzuki, T.; Aizawa, K.; Miyamoto, S.; Amaki, T.; Kawai-Kowase, K.; Sekiguchi, K.I.; Kurabayashi, M., 2002:
Phenotypic modulation of vascular smooth muscle cells: dissection of transcriptional regulatory mechanisms

Schmeisser, A.; Strasser, R.H., 2002:
Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells

Oliveira, A.M.; Nascimento, A.G., 2000:
Phenotypic plasticity and prognostic factors in extraskeletal myxoid chondrosarcoma

Sultan, S.E., 2002:
Phenotypic plasticity in plants: a case study in ecological development

Myers, P.; Lundrigan, B.L.; Gillespie, B.W.; Zelditch, M.L., 1996:
Phenotypic plasticity in skull and dental morphology in the prairie deer mouse (Peromyscus maniculatus bairdii)

Driver, C.P.; Shankar, K.R.; Jones, M.O.; Lamont, G.A.; Turnock, R.R.; Lloyd, D.A.; Losty, P.D., 2001:
Phenotypic presentation and outcome of esophageal atresia in the era of the Spitz classification

Ho, T.T.; Maguire, A.M.; Aguirre, G.D.; Surace, E.M.; Anand, V.; Zeng, Y.; Salvetti, A.; Hopwood, J.J.; Haskins, M.E.; Bennett, J., 2002:
Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI

Hyodo-Taguchi, Y.; Winkler, C.; Kurihara, Y.; Schartl, A.; Schartl, M., 1998:
Phenotypic rescue of the albino mutation in the medakafish (Oryzias latipes) by a mouse tyrosinase transgene

Pellegrin, I.; Segondy, M.; Garrigue, I.; Izopet, J.; Montes, B.; Pellegrin, J.L.; Reynes, J.; Massip, P.; Puel, J.; Fleury, H., 2001:
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy

Piketty, C.; Race, E.; Castiel, P.; Belec, L.; Peytavin, G.; Si-Mohamed, A.; Gonzalez-Canali, G.; Weiss, L.; Clavel, F.; Kazatchkine, M.D., 2000:
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz

Ivandic, V.; Hackett, C.A.; Zhang, Z.J.; Staub, J.E.; Nevo, E.; Thomas, W.T.; Forster, B.P., 2001:
Phenotypic responses of wild barley to experimentally imposed water stress

Thomson, C.E.; Montague, P.; Jung, M.; Nave, K.A.; Griffiths, I.R., 1997:
Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins

Yoshikawa, A.; Inada Ki, K-ichi.; Yamachika, T.; Shimizu, N.; Kaminishi, M.; Tatematsu, M., 2002:
Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression

Bitko, V.; Barik, S., 2002:
Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

Varho, T.T.; Alajoki, L.E.; Posti, K.M.; Korhonen, T.T.; Renlund, M.G.; Nyman, S.R.G.; Sillanpää, M.L.; Aula, P.P., 2002:
Phenotypic spectrum of Salla disease, a free sialic acid storage disorder

Lurie, I.W., 1998:
Phenotypic spectrum of tetrasomy 12p and prenatal counseling: potential underestimation of severity

Avila-Campos, M.J.; Padilla, G., 2001:
Phenotypic stability and plasmid detection in Actinobacillus actinomycetemcomitans

Tsang, K.Y.; Zhu, M.; Nieroda, C.A.; Correale, P.; Zaremba, S.; Hamilton, J.M.; Cole, D.; Lam, C.; Schlom, J., 1998:
Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen

Eatman, D.; Arthur, T.M.; Ahmed, S.; Grubbs, R.D., 2001:
Phenotypic stability of chick cardiomyocytes in serum-free media. Preservation of muscarinic receptor expression

Fries, B.C.; Goldman, D.L.; Casadevall, A., 2002:
Phenotypic switching in Cryptococcus neoformans

Goldman, D.L.; Fries, B.C.; Franzot, S.P.; Montella, L.; Casadevall, A., 1998:
Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents

Campos-Xavier, B.; Saraiva, J.M.; Savarirayan, R.; Verloes, A.; Feingold, J.; Faivre, L.; Munnich, A.; Le Merrer, M.; Cormier-Daire, V., 2002:
Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease

Sabgaĭda, T.P.; Orlov, V.S.; Adak, T., 2001:
Phenotypic variability in P. vivax with short- and long-term incubation period

Suzuki, Y.; Wada, T.; Sakai, T.; Ishikawa, Y.; Minami, R.; Tachi, N.; Saitoh, S. , 1998:
Phenotypic variability in a family with a mitochondrial DNA T8993C mutation

Pramstaller, P.P.; Kis, B.; Eskelson, C.; Hedrich, K.; Scherer, M.; Schwinger, E.; Breakefield, X.O.; Kramer, P.L.; Ozelius, L.J.; Klein, C., 2002:
Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene

Flück, C.; Deladoey, J.; Rutishauser, K.; Eblé, A.; Marti, U.; Wu, W.; Mullis, P.E., 1998:
Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C)

Ginkul, L.B.; Ermilov, A.N.; Mikulinskaia, S.M.; Shvemberger, I.N., 1999:
Phenotypic variability in gag-myc transgenic mice

Savage, M.O.; Blair, J.C.; Burren, C.P.; Camacho-Hübner, C.; Woods, K.A.; Metherell, L.; Clark, A.J.L., 2003:
Phenotypic variability in growth hormone insensitivity

Cavaliere, M.L.; Rinaldi, M.M.; Castelluccio, P.; Cioffi, C.; Vendemmia, M.; Vendemmia, S., 1997:
Phenotypic variability in the chromosome 9 ring

Mark, H.F., 1994:
Phenotypic variability in trisomy 8 mosaicism is consistent with the hypothesis of meiotic origin of trisomic neoplasms

Poulin, R.; Thomas, F., 1999:
Phenotypic variability induced by parasites:

Bentivoglio, A.Rita.; Loi, M.; Valente, E.M.; Ialongo, T.; Tonali, P.; Albanese, A., 2002:
Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia?

Kargatova, T.V.; Maksimova, E.E.; Popova, L.Iu.; Bril'kov, A.V.; Pechurkin, N.S., 1997:
Phenotypic variability of a recombinant luminescent strain of Escherichia coli in water microcosms

Landay, A.L.; Bethel, J.; Schnittman, S., 1998:
Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative

Breuning, M.H., 2002:
Phenotypic variability: genetics and chance--deletion 22q11 and schizophrenia

Howard, C.J.; Sopp, P.; Brownlie, J.; Parsons, K.R.; Lee, L.S., 1995:
Phenotypic variation and functional differences within dendritic cells isolated from afferent lymph

Sun, X.M.; Neuwirth, C.; Patel, D.D.; Knight, B.L.; Soutar, A.K., 1996:
Phenotypic variation and its correlation with mutations in the low density lipoprotein (LDL) receptor gene in familial hypercholesterolemia

Budka, H.; Hainfellner, J.A., 1996:
Phenotypic variation in Creutzfeldt-Jakob disease, May 31 and June 1, 1996, Vienna, Austria

Trujillo Tiebas, Mía.José.; Giménez Pardo, Aón.; García Sandoval, B.; Ayuso García, C., 2002:
Phenotypic variation in a family affected by autosomal dominant retinal dystrophy caused by the Gly208Asp mutation in the RDS peripherin gene

Lynch, H.T.; Brand, R.E.; Hogg, D.; Deters, C.A.; Fusaro, R.M.; Lynch, J.F.; Liu, L.; Knezetic, J.; Lassam, N.J.; Goggins, M.; Kern, S., 2002:
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

Lynch, H.T.; Conway, T.A.; Lynch, J.F., 1994:
Phenotypic variation in hereditary breast cancer. Cancer control implications

Koranteng, R.D.; Dearman, R.J.; Kimber, I.; Coleman, J.W., 2000:
Phenotypic variation in mast cell responsiveness to the inhibitory action of nitric oxide

Moran, A.P.; Knirel, Y.A.; Senchenkova, S'ya.N.; Widmalm, G.; Hynes, S.O.; Jansson, P-Erik., 2001:
Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H. Pylori lipopolysaccharides

Lapierre, J.; Dupouy-Camet, J., 1993:
Phenotypic variation of Plasmodium vivax

Lin, T.; Ichihara, S.; Yamada, Y.; Nagasaka, T.; Ishihara, H.; Nakashima, N.; Yokota, M., 2000:
Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe(110)-->Ile mutation in cardiac troponin T

Krutmann, J.; Funk, J.O.; Korge, B., 2001:
Phenotypic variations of the genotype: retrotransposons as epigenetic mediators?

Krueger, R.F., 2001:
Phenotypic, genetic, and nonshared environmental parallels in the structure of personality: a view from the multidimensional personality questionnaire

Virtanen, M.; Gedde-Dahl, T.; Mörk, N.J.; Leigh, I.; Bowden, P.E.; Vahlquist, A., 2001:
Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression

Muroi, K.; Yoshida, M.; Hatake, K.; Amemiya, Y.; Miura, Y., 1994:
Phenotypical analysis of acute lymphoblastic leukaemia at first relapse

Nagao, F.; Yabe, T.; Xu, M.; Okumura, K., 1995:
Phenotypical and functional analyses of natural killer cells from low NK activity individuals among healthy and patient populations

Betjes, M.G.; Tuk, C.W.; Beelen, R.H., 1993:
Phenotypical and functional characterization of dendritic cells in the human peritoneal cavity

Ureta-Vidal, A.; Firat, H.; Pérarnau, B.; Lemonnier, F.A., 1999:
Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice

Cavallin, F.; Traldi, A.; Zambello, R., 1993:
Phenotypical and functional evaluation of CD8+/S6F1+ T lymphocytes in haemophiliac individuals with HIV-1 infection

Yamasaki, M.; Ikeda, K.; Nakatani, K.; Yamamoto, T.; Kawai, Y.; Hirohashi, K.; Kinoshita, H.; Kaneda, K., 2000:
Phenotypical and morphological alterations to rat sinusoidal endothelial cells in arterialized livers after portal branch ligation

Cindik, E.D.; Maurer, M.; Hannan, M.K.; Müller, R.; Hayes, W.C.; Hovy, L.; Kurth, A.A., 2001:
Phenotypical characterization of c-kit receptor deficient mouse femora using non-destructive high-resolution imaging techniques and biomechanical testing

Nakahori, Y.; Lee, J.W.; Ewis, A.A.; Shinka, T., 2002:
Phenotypical difference between males of different Y chromosome lineage

Guillén, M.; Corella, D.; Luisa Cabello, M.; González, J.I.; Hernández Yago, J., 2001:
Phenotypical manifestations of cystinuria: a study of 20 families in the Community of Valencia

Hawkins, P.R.; Putt, E.; Falconer, I.; Humpage, A., 2002:
Phenotypical variation in a toxic strain of the phytoplankter, Cylindrospermopsis raciborskii (Nostocales, Cyanophyceae) during batch culture

Giese, K.C.; Spudich, J.A., 1997:
Phenotypically selected mutations in myosin's actin binding domain demonstrate intermolecular contacts important for motor function

McGue, M., 1999:
Phenotyping alcoholism

Atsuta, J.; Sterbinsky, S.A.; Plitt, J.; Schwiebert, L.M.; Bochner, B.S.; Schleimer, R.P., 1997:
Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1

Schuster, H., 1997:
Phenotyping and genotyping patients with cardiovascular risk factors

Li, Z.; Mo, Q.; Zhong, X.; Liu, L.; Xu, X., 2001:
Phenotyping and genotyping studies in a family with the compound heterozygosity for a deletional delta beta-thalassemia and a beta-thalassemia

Friedman, F.K.; Park, S.S.; Fujino, T.; Song, B.J.; Robinson, R.C.; West, D.; Radkowsky, A.K.; Miller, H.; Gelboin, H.V., 1984:
Phenotyping cytochromes P450 with monoclonal antibodies

Synnott, I.H., 1997:
Phenotyping for CYP 11D6 alleles

Konopka, M.; Trzciński, K.; Tyski, S.; Hryniewicz, W., 1996:
Phenotyping methods in epidemiological analysis of epidemic Staphylococcus aureus strains

Iannone, F..; Corrado, A..; Grattagliano, V..; Cantatore, F..P..; Patella, V..; Lapadula, G.., 2002:
Phenotyping of chondrocytes from human osteoarthritic cartilage: chondrocyte expression of beta integrins and correlation with anatomic injury

Pastera, J.; Anzenbacher, P.; Fiala, Z., 2001:
Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics

Tran, A.; Yang, G.; Doglio, A.; Ticchioni, M.; Laffont, C.; Durant, J.; Bernard, J.L.; Gugenheim, J.; Saint-Paul, M.C.; Bernard, A.; Rampal, P.; Benzaken, S., 1998:
Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C

Di Sabatino, A.; Bertrandi, E.; Casadei Maldini, M.; Pennese, F.; Proietti, F.; Corazza, G.R., 1999:
Phenotyping of peripheral blood lymphocytes in adult coeliac disease

Ponzone, A.; Spada, M.; de Sanctis, L.; Dianzani, I., 1996:
Phenotyping of phenylketonuric patients by oral phenylalanine loading

Kurył, J., 2000:
Phenotyping of porcine apolipoprotein E using isoelectric focusing and localization of the APOE gene within the halothane-susceptibility linkage group

Mukanganyama, S.; Masimirembwa, C.M.; Naik, Y.S.; Hasler, J.A., 1998:
Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A

Fredrickson, D.S.; Frederickson, D.S., 1993:
Phenotyping. On reaching base camp (1950-1975)

Constantinou, A.I.; Husband, A., 2003:
Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex

Kolmodin-Hedman, B., 1994:
Phenoxyacetates

Al-Ali, M.; Salman, G.; Rasheed, A.; Al-Ani, G.; Al-Rubaiy, S.; Alwan, A.; Al-Shaikli, A., 1999:
Phenoxybenzamine in the management of neuropathic bladder following spinal cord injury

Dipp, M.A.; Nye, P.C.; Taggart, D.P., 2001:
Phenoxybenzamine is more effective and less harmful than papaverine in the prevention of radial artery vasospasm

Taggart, D.P.; Dipp, M.; Mussa, S.; Nye, P.C., 2000:
Phenoxybenzamine prevents spasm in radial artery conduits for coronary artery bypass grafting

Gärtner, B.C.; Seifert, C.B.; Michalk, D.V.; Roth, B., 1993:
Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives

Weber, T.; Hinterreiter, M.; Knoflach, P., 2001:
Phenprocoumon-associated necrotizing hepatitis

Shaw, K.T.; Utsuki, T.; Rogers, J.; Yu, Q.S.; Sambamurti, K.; Brossi, A.; Ge, Y.W.; Lahiri, D.K.; Greig, N.H., 2001:
Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development

Rothman, R.B.; Ayestas, M.; Baumann, M.H., 1996:
Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine

Cleare, A.J., 1996:
Phentermine, psychosis, and family history

Coyne, T.C., 1997:
Phentermine--resin or salt--there are differences

McCleane, G.J., 1996:
Phentolamine abolishes the pain of chronic pancreatitis

Dana, A.; Imagawa, J.; Yellon, D.M., 1998:
Phentolamine and preconditioning during coronary angioplasty

Chen, J.T.; Chen, S.M.; Kuan, T.S.; Chung, K.C.; Hong, C.Z., 1998:
Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle

Galal, O.; Kalloghlian, A.; Pittappilly, B.M.; Dzimiri, N., 1999:
Phentolamine improves clinical outcome after balloon valvoplasty in neonates with severe pulmonary stenosis

Høy, M.; Bokvist, K.; Xiao-Gang, W.; Hansen, J.; Juhl, K.; Berggren, P.O.; Buschard, K.; Gromada, J., 2000:
Phentolamine inhibits exocytosis of glucagon by Gi2 protein-dependent activation of calcineurin in rat pancreatic alpha -cells

McCleane, G.J., 1996:
Phentolamine mesylate can alleviate the nausea and vomiting associated with liver metastasis

Rubio-Aurioles, E.; Lopez, M.; Lipezker, M.; Lara, C.; Ramírez, A.; Rampazzo, C.; Hurtado de Mendoza, Mía.T.; Lowrey, F.; Loehr, L.A.; Lammers, P., 2002:
Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study

Hinterberger, J.W.; Kintzi, H.E., 1994:
Phentolamine reversal of epinephrine-induced digital vasospasm. How to save an ischemic finger

Anonymous, 1999:
Phenyl glycidyl ether

Preda; Scott, 2000:
Phenyl migrations in dehydroaromatic compounds. A new mechanistic link between alternant and nonalternant hydrocarbons at high temperatures

Krings, U.; Pilawa, S.; Theobald, C.; Berger, R.G., 2001:
Phenyl propenoic side chain degradation of ferulic acid by Pycnoporus cinnabarinus - elucidation of metabolic pathways using [5-2H]-ferulic acid

Chen; Brunskill; Hall; Lalancette; Thompson, 2000:
Phenyl- and mesitylglyoxylic acids: catemeric hydrogen bonding in two alpha-keto acids

Asensio, A.; Dannenberg, J.J., 2001:
Phenyl-bridging in the 2-phenylethyl radical. A molecular orbital study

Letzel, T.; Pöschl, U.; Wissiack, R.; Rosenberg, E.; Grasserbauer, M.; Niessner, R., 2001:
Phenyl-modified reversed-phase liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry: a universal method for the analysis of partially oxidized aromatic hydrocarbons

Ponzini; Zagha; Hardcastle; Siegel, 2000:
Phenyl/Pentafluorophenyl Interactions and the Generation of Ordered Mixed Crystals: sym-Triphenethynylbenzene and sym-Tris(perfluorophenethynyl)benzene This work was supported by the US National Science Foundation (CHE-9904275)

Samid, D.; Hudgins, W.R.; Shack, S.; Liu, L.; Prasanna, P.; Myers, C.E., 1997:
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers

Prasanna, P.; Shack, S.; Wilson, V.L.; Samid, D., 1995:
Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis

Henze, O.; Lentz, D.; Schäfer, A.; Franke, P.; Schlüter, A.Dieter., 2002:
Phenylacetylene macrocycles with two opposing bipyridine donor sites: syntheses, X-ray structure determinations, and Ru complexation

Gloge, A.; Zoń, J.; Kövári, A.; Poppe, L.; Rétey, J., 2000:
Phenylalanine ammonia-lyase: the use of its broad substrate specificity for mechanistic investigations and biocatalysis--synthesis of L-arylalanines

Marchini, J.S.; Castillo, L.; Chapman, T.E.; Vogt, J.A.; Ajami, A.; Young, V.R., 1993:
Phenylalanine conversion to tyrosine: comparative determination with L-[ring-2H5]phenylalanine and L-[1-13C]phenylalanine as tracers in man

Sarciron, M.E.; Walchshofer, N.; Paris, J.; Petavy, A.F.; Peyron, F., 1999:
Phenylalanine derivatives active against Toxoplasma gondii brain cysts in mice

Wiens, M.; Koziol, C.; Batel, R.; Müller, W.E., 1999:
Phenylalanine hydroxylase from the sponge Geodia cydonium: implication for allorecognition and evolution of aromatic amino acid hydroxylases

Lilleväli, H.; Ounap, K.; Metspalu, A., 1996:
Phenylalanine hydroxylase gene mutation R408W is present on 84% of Estonian phenylketonuria chromosomes

Verduci, E.; Riva, E.; Agostoni, C.; Leviti, S.; Fiori, L.; Lammardo, A.M.; Biondi, M.L.; Giovannini, M., 2002:
Phenylalanine hydroxylase mutations and phenylalanine-tyrosine metabolism in heterozygotes for phenylalanine hydroxylase deficiency

Hauer, C.R.; Rebrin, I.; Thöny, B.; Neuheiser, F.; Curtius, H.C.; Hunziker, P.; Blau, N.; Ghisla, S.; Heizmann, C.W., 1993:
Phenylalanine hydroxylase-stimulating protein/pterin-4 alpha-carbinolamine dehydratase from rat and human liver. Purification, characterization, and complete amino acid sequence

Hamaguchi, N.; True, T.A.; Saussy, D.L.; Jeffs, P.W., 1996:
Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists

Sahay, S., 2000:
Phenylalanine transport in Aspergillus nidulans: demonstration of role of phenylalanine binding proteins

Stoll, B.; Burrin, D.G.; Henry, J.; Jahoor, F.; Reeds, P.J., 1998:
Phenylalanine utilization by the gut and liver measured with intravenous and intragastric tracers in pigs

Burkhart, C.G.; Burkhart, C.N., 1999:
Phenylalanine with UVA for the treatment of vitiligo needs more testing for possible side effects

Zhang, L.; Lockwood, T.D., 1993:
Phenylalaninylargininylarginine: a novel tripeptide exerting Zn(2+)-dependent, insulin-mimetic inhibitory action on myocardial proteolysis

Kavanagh, P..; Dunne, J..; Feely, J..; Maguire, R..; Corrigan, D..; Keating, J..J..; Meegan, M..J..; Clancy, J..M..; Burdett, J.., 2001:
Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland

Kiseleva, M.G.; Nesterenko, P.N., 2001:
Phenylaminopropyl silica--a new specific stationary phase for high-performance liquid chromatography of phenols

Bogumil, R.; Ullrich, V., 2002:
Phenylarsine oxide affinity chromatography to identify proteins involved in redox regulation: dithiol-disulfide equilibrium in serine/threonine phosphatase calcineurin

Doussiere, J.; Poinas, A.; Blais, C.; Vignais, P.V., 1998:
Phenylarsine oxide as an inhibitor of the activation of the neutrophil NADPH oxidase--identification of the beta subunit of the flavocytochrome b component of the NADPH oxidase as a target site for phenylarsine oxide by photoaffinity labeling and photoinactivation

Su, Y.; Block, E.R., 2001:
Phenylarsine oxide inhibits nitric oxide synthase in pulmonary artery endothelial cells

Krutetskaia, Z.I.; Lebedev, O.E.; Krutetskaia, N.I.; Butov, S.N.; Petrova, T.V., 1997:
Phenylarsine oxide, a tyrosine phosphatase inhibitor, induces an increase in the intracellular concentration of calcium in rat peritoneal macrophages and human fibroblasts

Ungureanu, I.; Klotz, P.; Mann, Aé., 2001:
Phenylaziridine as a Masked 1,3 Dipole in Reactions with Nonactivated Alkenes We thank Professor C. G. Wermuth for stimulating discussions

Raghavendra, M.P.; Prakash, V., 2002:
Phenylboronic acid--a potent inhibitor of lipase from Oryza sativa

Giltay, E.J.; Popp-Snijders, C.; van Denderen, J.C.; van Schaardenburg, D.; Gooren, L.J.; Dijkmans, B.A., 2001:
Phenylbutazone can spuriously elevate unextracted testosterone assay results in patients with ankylosing spondylitis

Miura, T.; Muraoka, S.; Fujimoto, Y., 2001:
Phenylbutazone radicals inactivate creatine kinase

Viseux, V.; Béguin, L.; Poulain, J.F.; Sarraj, A.; Mayeux, I.; Carmi, E.; Lafon, B.; Lok, C., 2002:
Phenylbutazone-induced sialadenitis fever simulating angioedema

Carducci, M.A.; Nelson, J.B.; Chan-Tack, K.M.; Ayyagari, S.R.; Sweatt, W.H.; Campbell, P.A.; Nelson, W.G.; Simons, J.W., 1996:
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate

Bar-Ner, M.; Thibault, A.; Tsokos, M.; Magrath, I.T.; Samid, D., 1999:
Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells

Vander Mijnsbrugge, K.; Beeckman, H.; D.R.cke, R.; Van Montagu, M.; Engler, G.; Boerjan, W., 2000:
Phenylcoumaran benzylic ether reductase, a prominent poplar xylem protein, is strongly associated with phenylpropanoid biosynthesis in lignifying cells

Bagchi, S.; Deshpande, S.B., 2003:
Phenyldiguanide activates cardiac receptors to produce responses by involving three different efferent pathways in anaesthetized rats

Liu, R.; Marra, R.M..; Tidwell, T.T.., 1996 :
Phenyldimethylsilyl-Substituted Ketenes and Bisketenes

Kosynkin, D.V.; Tour, J.M., 2001:
Phenylene ethynylene diazonium salts as potential self-assembling molecular devices

Anderson, S., 2002:
Phenylene ethynylene pentamers for organic electroluminescence

Anand, A.; Andrade, C.; Sudha, S.; Guido, S.; Venkataraman, B.V., 2001:
Phenylephrine and ECS-induced retrograde amnesia

Troncy, E.; Blaise, G., 1998:
Phenylephrine and inhaled nitric oxide

Pearl, R.G., 1997:
Phenylephrine and inhaled nitric oxide in adult respiratory distress syndrome. When are two better than one?

Chin, K.W.; Law, N.M.; Chin, M.K., 1994:
Phenylephrine eye drops in ophthalmic surgery--a clinical study on cardiovascular effects

Campbell, L.A.; Batra, E.; Bay, C.; Bergeson, P.S., 1999:
Phenylephrine hydrochloride nose drops in adjunctive treatment of respiratory syncytial virus infection

Watts, A.D.J.; Wyss, A.J.; Gelb, A.W., 2002:
Phenylephrine increases cerebral perfusion pressure without increasing intracranial pressure in rabbits with balloon-elevated intracranial pressure

Baghelai, K.; Graham, L.J.; Wechsler, A.S.; Jakoi, E.R., 1999:
Phenylephrine induces delayed cardioprotection against necrosis without amelioration of stunning

Brodskiĭ, V.Ia.; Nechaeva, N.V.; Avdonin, P.V.; Zvezdina, N.D.; Novikova, T.E.; Gvazava, I.G.; Fateeva, V.I., 2000:
Phenylephrine synchromizes rhythm of protein synthesis in hepatocyte culture

Kanbak, M., 1998:
Phenylephrine, dopamine, mannitol, and renal protection during cardiopulmonary bypass

Li, J.; Zhao, Y.; Wang, B.; Cui, J., 2000:
Phenylethanoid glucosides from flos Buddlejae

Zhou, B.N.; Bahler, B.D.; Hofmann, G.A.; Mattern, M.R.; Johnson, R.K.; Kingston, D.G., 1998:
Phenylethanoid glycosides from Digitalis purpurea and Penstemon linarioides with PKCalpha-inhibitory activity

Miyase, T.; Yamamoto, R.; Ueno, A., 1996:
Phenylethanoid glycosides from Stachys officinalis

Nakai, T.; Isobe, K.; Matsui, Y., 1999:
Phenylethanolamine N-methyltransferase

Marino-Neto, J.; Armengol, J.A., 2001:
Phenylethanolamine N-methyltransferase-immunoreactive neurons in the medulla oblongata of the pigeon (Columba livia) projecting to the hypothalamic paraventricular nucleus

Nagatsu, I.; Ikemoto, K.; Takeuchi, T.; Arai, R.; Karasawa, N.; Fujii, T.; Nagatsu, T., 1998:
Phenylethanolamine-N-methyltransferase - immunoreactive nerve terminals afferent to the mouse substantia nigra

Sabelli, H.; Fahrer, R.; Medina, R.D.; Ortiz Fragola, E., 1994:
Phenylethylamine relieves depression after selective MAO-B inhibition

Szabo, A.; Billett, E.; Turner, J., 2001:
Phenylethylamine, a possible link to the antidepressant effects of exercise?

Yabuuchi; Kusumi, 2000:
Phenylglycine methyl ester, a useful tool for absolute configuration determination of various chiral carboxylic acids

Sheardown, M.J.; Thomsen, C., 1996:
Phenylglycines can evoke quisqualate-primed depolarizations in rat cingulate cortex: an effect associated with [3H]DL-AP4 uptake

Zhu, Q.; Wu, J.; Fathi, R.; Yang, Z., 2002:
Phenyliodonium zwitterion as an efficient electrophile in the palladium-catalyzed suzuki-type reaction: a novel method for the synthesis of 3-aryl-4-hydroxycoumarins

Motorina, I.A.; Huel, C.; Quiniou, E.; Mispelter, J.; Adjadj, E.; Grierson, D.S., 2001:
Phenylisoserine: a versatile amino acid for the construction of novel beta-peptide structures

Anonymous, 2002:
Phenylketonuria (PKU): screening and management

Yilmazer, T.; van Gennip, A.H.; Abeling, N.G.G.M.; Ozalp, I.; Coşkun, T.; Bakker, H.D., 2002:
Phenylketonuria and glycogen storage disease type III in sibs of one family

Endres, W., 1994:
Phenylketonuria and its treatment in and beyond adolescence

Purnell, H., 2001:
Phenylketonuria and maternal phenylketonuria

Anonymous, 1993:
Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria

van der Sijs-Bos, C.J.; Diepstraten, C.M.; Juyn, J.A.; Plaisier, M.; Giltay, J.C.; van Spronsen, F.J.; Smit, G.P.; Berger, R.; Smeitink, J.A.; Poll-The, B.T.; Ploos van Amstel, J.K., 1996:
Phenylketonuria in The Netherlands: 93% of the mutations are detected by single-strand conformation analysis

Voogd, C.E., 1993:
Phenylketonuria inspite of screening

Jäckle, R., 2002:
Phenylketonuria outgrows childhood shoes. How much is diet still necessary?

Ellingsen, S.; Knappskog, P.M.; Eiken, H.G., 1997:
Phenylketonuria splice mutation (EXON6nt-96A-->g) masquerading as missense mutation (Y204C)

Anonymous, 1975:
Phenylketonuria tests

Ishimaru, K.; Tamasawa, N.; Baba, M.; Matsunaga, M.; Takebe, K., 1993:
Phenylketonuria with adult-onset neurological manifestation

Anonymous, 1996:
Phenylketonuria, an international survey of management over 40 years. Proceedings of a workshop. Fulda, November 16-19, 1994

Penrose, L.S., 1998:
Phenylketonuria--a problem in eugenics

Weglage, J.; Fünders, B.; von Teeffelen-Heithoff, A.; Ullrich, K., 1993:
Phenylketonuria--change in therapeutic strategies. Study of intellectual development and dietary compliance of young phenylketonuria patients

van Spronsen, F.J.; Reijngoud, D.J.; Smit, G.P.; Nagel, G.T.; Stellaard, F.; Berger, R.; Heymans, H.S., 1998:
Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased

de Valk, H.W.; de Sonneville, L.M.; Duran, M.; Poll-The, B.T.; Erkelens, D.W., 2000:
Phenylketonuria: a children's disease in adulthood

Burgard, P.; Link, R.; Schweitzer-Krantz, S., 2001:
Phenylketonuria: evidence-based clinical practice. Summary of the roundtable discussion

Li, D.; Zheng, Z-Lian.; Yang, R.; Zhang, P., 2018:
Analytical Solutions for Stochastic Vibration of Orthotropic Membrane under Random Impact Load

Weglage, J.; Fünders, B.; von Teeffelen-Heithoff, A.; Ullrich, K., 1993:
Phenylketonuria: illness experience and coping mechanisms

Anonymous, 1978:
Phenylketonuria; congenital hypothyroidism; meniscocytosis

Gombos, B.; Merva, M.; Sekula, F.; Koci, M., 1996:
Phenylmercury and its mobilization in the organism by a metal complex-forming substance: 2,3-dimercapto-1-propane sodium sulfonate

Terán, C.; Santana, L.; Uriarte, E.; Fall, Y.; Unelius, L.; Tolf, B.R., 1999:
Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors

Rothman, R.B.; Xu, H.; Char, G.U.; Kim, A.; De Costa, B.R.; Rice, K.C.; Zimmerman, D.M., 1993:
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site

Weisshaar, B.; Jenkins, G.I., 1999:
Phenylpropanoid biosynthesis and its regulation

Martins, R.C.; Latorre, L.R.; Sartorelli, P.; Kato, M.J., 2001 :
Phenylpropanoids and tetrahydrofuran lignans from Piper solmsianum

Ernst, M.E.; Hartz, A., 2001:
Phenylpropanolamine and hemorrhagic stroke

Anonymous, 2000:
Phenylpropanolamine and other OTC alpha-adrenergic agonists

Mersfelder, T.L., 2001:
Phenylpropanolamine and stroke: the study, the FDA ruling, the implications

Charatan, F., 2000:
Phenylpropanolamine in drugs could be a risk for stroke

Kuchel, O., 2001:
Phenylpropanolamine, stroke and hypertension

Hamilton, R.S.; Sharieff, G., 2000:
Phenylpropanolamine-associated intracranial hemorrhage in an infant

Kwon, O.Eok.; Rho, M-Chual.; Song, H.Young.; Lee, S.Woong.; Chung, M.Yeon.; Lee, J.Hyun.; Kim, Y.Ho.; Lee, H.Sun.; Kim, Y-Kook., 2003:
Phenylpyropene A and B, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Penicillium griseofulvum F1959

Gürses-Ozden, R.; Emarah, A.; Liebmann, J.M.; Ritch, R., 2001:
Phenylthiocarbamide taste testing in patients with pigmentary glaucoma

Elsalini, O.A.; Rohr, K.B., 2003:
Phenylthiourea disrupts thyroid function in developing zebrafish

Kimura, S.; Bill, E.; Bothe, E.; Weyhermüller, T.; Wieghardt, K., 2001:
Phenylthiyl radical complexes of gallium(III), iron(III), and cobalt(III) and comparison with their phenoxyl analogues

Schebler, P.J..; Riordan, C.G..; Guzei, I.A..; Rheingold, A.L.., 2001:
Phenyltris((tert-butylthio)methyl)borate: A Second Generation S(3)(-) Ligand That Enforces Tetrahedral Coordination

Zamboni, W.C.; Gajjar, A.J.; Heideman, R.L.; Beijnen, J.H.; Rosing, H.; Houghton, P.J.; Stewart, C.F., 1998:
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma

Harrison, M.B.; Lyons, G.R.; Landow, E.R., 1993:
Phenytoin and dyskinesias: a report of two cases and review of the literature

Tse, C.S.; Iagmin, P., 1994:
Phenytoin and ranitidine interaction

Kasuya, H.; Shimizu, T.; Sasahara, A.; Takakura, K., 1999:
Phenytoin as a liquid material for embolisation of tumours

Lucas, L.S.; Jordan, E.T., 1997:
Phenytoin as an alternative treatment for preeclampsia

Trevisol-Bittencourt, P.C.; da Silva, V.R.; Molinari, M.A.; Troiano, A.R., 2001:
Phenytoin as the first option in female epileptic patients?

Mangalvedhekar, S.S.; Gogtay, N.J.; Manjula, S.; Kadam, V.S.; Dalvi, S.S.; Shah, P.U.; Badakere, S.S.; Pradhan, V.D.; Kshirsagar, N.A., 2002:
Phenytoin associated alopecia: drug induced lupus

Sharfstein, J.; Agrawal, D.; Jeffrey, P., 1998:
Phenytoin dosage

Knox, G.W.; Woodard, D.; Chelen, W.; Ferguson, R.; Johnson, L., 1994:
Phenytoin for motion sickness: clinical evaluation

Horsmans, Y.; Van den Berge, V.; Bouckaert, A.; Desager, J.P., 1998:
Phenytoin hydroxylation in a healthy Caucasian population: bimodal distribution of hydroxyphenytoin urinary excretion

Chee, W.W.; Jansen, C.E., 1994:
Phenytoin hyperplasia occurring in relation to titanium implants: a clinical report

Adjei, O.; Evans, M.R.; Asiedu, A., 1998:
Phenytoin in the treatment of Buruli ulcer

Gimeno Calvo, B., 2000:
Phenytoin in the treatment of epilepsy in women

Hunt, E.A., 2002:
Phenytoin in traumatic brain injury

Chaudhary, N.; Ravat, S.H.; Shah, P.U., 1998:
Phenytoin induced dyskinesia

Jaramillo, M.J.; Stewart, K.J.; Kolhe, P.S., 2000:
Phenytoin induced rhinophyma treated by excision and full thickness skin grafting

Kakar, A.; Byotra, S.P., 2000:
Phenytoin induced severe agranulocytosis and hepatitis

Mihalache, G.; Păduraru, D.; Zamfir, C.L.; Grigore, M.; Filipoiu, F.; Indrei, A., 2002:
Phenytoin influence on human metanephros

Vasconcelos, D., 1997:
Phenytoin monitoring in pregnancy and puerperium

Rodríguez Gaspar, M.A.; Martínez Riera, A.; González Reimers, E.; Santolaria Fernández, F., 2001:
Phenytoin neurotoxicity

Dahm, A.Erik.Astrup.; Brørs, O., 2002:
Phenytoin poisoning caused by interaction with ticlopidine

Rodríguez-Palomares, C.; Belmont-Gómez, A.; Amancio-Chassin, O.; Estrada-Altamirano, A.; Herrerías-Cunedo, T.; Hernández-Serrano, M., 1995:
Phenytoin serum concentration monitoring during pregnancy and puerperium in Mexican epileptic women

Misra, S.; Chakraborty, S.; Gangopadhyay, P.; Basu, N., 2000:
Phenytoin sodium induced diabetes insipidus

Yazici, E.; Oner, L.; Kaş, H.S.; Hincal, A.A., 1996:
Phenytoin sodium microcapsules: bench scale formulation, process characterization and release kinetics

Kaatz, B., 1997:
Phenytoin suppositories and echinacea

Lewin, S.; Rao, S.D.; Chandrasekhara, M.K.; Vengamma, B., 1993:
Phenytoin toxic encephalopathy

Rindone, J.P.; Bryan, G., 1996:
Phenytoin toxicity associated with ticlopidine administration

Chandra, R.S.; Dalvi, S.S.; Powar, H.S.; Karnad, P.D.; Kshirsagar, N.A., 1993:
Phenytoin toxicity due to rifampicin induced hepatic dysfunction

Neubauer, D.; Novosel-Sever, M., 2001:
Phenytoin treatment in the newborn and infant

Tudur Smith, C.; Marson, A.G.; Williamson, P.R., 2001:
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures

Chi, W.M.; Chua, K.S.; Kong, K.H., 2000:
Phenytoin-induced asterixis--uncommon or under-diagnozed?

Shulman, L.M.; Singer, C.; Weiner, W.J., 1996:
Phenytoin-induced focal chorea

Colombo-Arnet, E., 2000:
Phenytoin-induced hypersensitivity reaction with liver failure

Chakravarty, K.; al-Jafari, M.S., 1996:
Phenytoin-induced pseudo-Sjögren's syndrome

Cohen, A.D.; Reichental, E.; Halevy, S., 2000:
Phenytoin-induced severe cutaneous drug reactions: suspected interactions with corticosteroids and H2-blockers

Salzman, M.B.; Smith, E.M., 1998:
Phenytoin-induced thrombocytopenia treated with intravenous immune globulin

Kayal, J.D.; Ling, M., 1998:
Phenytoin-induced verrucous eruption

Shores, M.M.; Sloan, K.L., 2002:
Phenytoin-induced visual disturbances misdiagnosed as alcohol withdrawal

Soory, M.; Suchak, A., 2002:
Phenytoin-mediated androgen metabolism in gingival fibroblasts. Effects of the antiandrogen finasteride and the alkaline phosphatase inhibitor levamisole

Koukkari, M.W.; Vanefsky, M.A.; Steinberg, G.K.; Hahn, J.S., 1996:
Phenytoin-related chorea in children with deep hemispheric vascular malformations

Morse, T.G.; Zeigler, V., 1994:
Phenytoin. It's not just for seizures anymore

Iivanainen, M., 1999:
Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability

Burgos Peláez, R.; Simó Canonge, R.; Hernández-Pascual, C.; Mesa Manteca, J., 1994:
Pheochromocytoma and Von-Hippel-Lindau disease

Alvarez, J.; Mancha, I.; Vivancos, R.; Vázquez, F.; Olveira, G.; de Mora, M.; Soriguer, F.; Malpartida, F., 1998:
Pheochromocytoma and cardiac insufficiency

Juneja, R.; Krishnamani, N.C.; Kothari, S.S.; Guleria, S.; Mahawar, R.M., 2000:
Pheochromocytoma and congenital cyanotic heart disease

Burgos Peláez, R.; Simó Canonge, R.; Mesa Manteca, J.; Boada Playá, X., 1994:
Pheochromocytoma and ischemic cardiopathy

Young, W.F., 1997:
Pheochromocytoma and primary aldosteronism

Young, W.F., 1998:
Pheochromocytoma and primary aldosteronism: diagnostic approaches

Lam, J.; Henríquez, R.; Cruzat, C., 1999:
Pheochromocytoma and von Recklinghausen neurofibromatosis: postpartum crisis and renal artery thrombosis

Rabii, R.; Fekak, H.; Moufid, K.; Joual, A.; Bennani, S.; el Mrini, M.; Benjelloun, S., 2002:
Pheochromocytoma and von Recklinghausen's disease

Tack, C.J.; Lenders, J.W., 1993:
Pheochromocytoma as a cause of blue toes

Maassen van den Brink, K.I.; Tan, P.B.; Boerma, E.J.; Keuning, J.F.; van Nieuwenhuizen, P.J., 1997:
Pheochromocytoma as a cause of collapse and hypertension during a stay in the tropics

Gluvić, Z.; Rasić-Milutinović, Z., 2002:
Pheochromocytoma associated with cholelithiasis

Lecube, A.; Hernández, C.; Oriola, J.; Tovar, J.L.; Gémar, E.; Baena, J.A.; Mesa, J.; Simó, R., 2000:
Pheochromocytoma associated with multiple endocrine neoplasia 2A and sporadic: differential characteristics

Castaigne, V.; Afriat, R.; Cambouris-Perrine, S.; Radu, S.; Desdouit, J.; Freund, M., 1998:
Pheochromocytoma associated with pregnancy. Report of 2 cases and review of the literature

Ahlawat, S.K.; Jain, S.; Kumari, S.; Varma, S.; Sharma, B.K., 1999:
Pheochromocytoma associated with pregnancy: case report and review of the literature

Powers, J.F.; Evinger, M.J.; Tsokas, P.; Bedri, S.; Alroy, J.; Shahsavari, M.; Tischler, A.S., 2001:
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice

Kim, H.J.; Kim, D.K.; Lee, S.C.; Yang, S.H.; Yang, J.H.; Lee, W.R., 1998:
Pheochromocytoma complicated with cardiomyopathy after delivery--a case report and literature review

Landsberg, L., 1994:
Pheochromocytoma complicating pregnancy

Khaleq, K.; Miloudi, Y.; Idali, B.; Harti, A.; Barrou, L., 2002:
Pheochromocytoma discovered in the preoperative period: analysis of 3 cases

Norton, K.S.; Girod, W.; Johnson, L.W., 2001:
Pheochromocytoma during pregnancy: a case report

Chittacharoen, A.; Phuapradit, W., 1997:
Pheochromocytoma during pregnancy: case report

Sidibe, E.H., 2001:
Pheochromocytoma in Africa: rarity, gravity and ectopy

Szmidt, L.; Symonides, B.; Poor, H.F.; Januszewicz, A.; Lapiński, M.; Wocial, B., 1997:
Pheochromocytoma in a 81 year old woman treated with surgery--case report

Zili, J.; Maatouk, F.; Monastiri, F.; Ayari, M.; Mhalla, S.; Gamra, H.; Betbout, F.; Benfarhat, M.H., 1995:
Pheochromocytoma in a patient with Recklinghausen disease

Potts, J.M.; Larrimer, J., 1994:
Pheochromocytoma in a pregnant patient

Liu, F.H.; Hsu, B.R.; Tsai, J.S., 1996:
Pheochromocytoma in a pregnant woman

Martínez Brocca, M.A.; Acosta Delgado, D.; Quijada, D.; Navarro González, E.; Soto Moreno, A.; Gonzáles Duarte, D.; del Valle López de Ayala, A.; Astorga Jiménez, R., 2002:
Pheochromocytoma in a pregnant woman with multiple endocrine neoplasia type 2a

Ciftci, A.O.; Tanyel, F.C.; Senocak, M.E.; Büyükpamukçu, N., 2001:
Pheochromocytoma in children

Misra, A.K.; Agarwal, G.; Mishra, A.; Agarwal, A.; Bhatia, V.; Mishra, S.K., 2002:
Pheochromocytoma in children and adolescents: an institutional experience

Zerhouni, H.; Kaddouri, N.; Abdelhak, M.; Benhmamouch, N.; Barahioui, M., 2002:
Pheochromocytoma in children. Two case reports

Fernández Córdoba, M.S.; López Saiz, A.; Benlloch Sánchez, C.; Velázquez Terrón, J.; Costa Borrás, E.; Segarra Llido, V.; Vicent Carsi, V., 1996:
Pheochromocytoma in children: 2 cases

Barthez, P.Y.; Marks, S.L.; Woo, J.; Feldman, E.C.; Matteucci, M., 1998:
Pheochromocytoma in dogs: 61 cases (1984-1995)

Takai, Y.; Seki, H.; Kinoshita, K., 1998:
Pheochromocytoma in pregnancy manifesting hypertensive crisis induced by metoclopramide

Almog, B.; Kupferminc, M.J.; Many, A.; Lessing, J.B., 2000:
Pheochromocytoma in pregnancy--a case report and review of the literature

Smith, C.M.; Wigent, P.J., 1998:
Pheochromocytoma in pregnancy: considerations for the advanced practice nurse

Koch, C.A.; Mauro, D.; Walther, M.M.; Linehan, W.Marston.; Vortmeyer, A.O.; Jaffe, R.; Pacak, K.; Chrousos, G.P.; Zhuang, Z.; Lubensky, I.A., 2002:
Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2

Bessis, D.; Dereure, O.; Le Quellec, A.; Ciurana, A.J.; Guilhou, J.J., 1998:
Pheochromocytoma manifesting as toe necrosis

Ford, J.; Rosenberg, F.; Chan, N., 1997:
Pheochromocytoma manifesting with shock presents a clinical paradox: a case report

Torregrosa Pérez, N.M.; M Rodríguez González, J.M.; Hernández Martínez, A.; Parrilla Paricio, P., 2001:
Pheochromocytoma mimicking diabetic mellitus with ketoacidosis

Hocqueloux, L.; Barboteu, M.; Vincent, F.; Meria, P.; Le Gall, J.R., 1998:
Pheochromocytoma mimicking septic shock

Shapira, M.Y.; Zuckerman, E.; Zuebi, T.; Jurim, O., 1999:
Pheochromocytoma multi-organ crisis: nonseptic hyperthermia and shock

Caputo, C.; Fishbane, S.; Shapiro, L.; Courgi, R.G.; Kostadinov, S.; Donovan, V.; Epstein, D., 2002:
Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis

Huang, S.T.; Lai, M.K.; Sun, C.C.; Chen, C.S.; Chen, W.H., 1993:
Pheochromocytoma nuclear pattern analysis by flow cytometry

Afriat, R.; Villeneuve, A.; Maitre, F.; Bardaxoglou, E.; Maurel, J.P.; Grossetti, D., 1993:
Pheochromocytoma of the broad ligament

Kihara, H.; Terai, H.; Kihara, Y.; Kihara, T.; Takahashi, H.; Kosuda, A.; Shimomoto, M.; Fukunishi, M.; Tanaka, T., 1997:
Pheochromocytoma of the left retroperitoneal paraganglion associated with torsade de pointes: a case report

Giménez Bachs, J.M.; Salinas Sánchez, A.S.; Lorenzo Romero, J.G.; Segura Martín, M.; Hernández Millán, I.; Barba Romero, M.A.; Virseda Rodríguez, J.A., 2002:
Pheochromocytoma of the organ of Zuckerkandl. Apropos of a case

Peczkowska, M.; Gessek, J.; Januszewicz, A.; Neumann, H.P.H.; Januszewicz, M.; Janaszek-Sitkowska, H.; Prejbisz, A.; Kabat, M.; Skierski, J.; Cieśla, W.; Szostek, Mław., 2002:
Pheochromocytoma of the urinary bladder coexisting with another extra-adrenal tumour--case report of a 19-year-old male patient

Jorge, A.A.; Lucon, A.M.; Bloise, W.; Mendonça, B.B., 1997:
Pheochromocytoma of the urinary bladder, report of a case and review of the literature

Lee, S.P.; Wang, G.G.; Hwang, S.C.; Chen, M.T.; Lin, H.D., 1996:
Pheochromocytoma of the urinary bladder: a case report

Karpman, E.; Zvara, P.; Stoppacher, R.; Jackson, T.L.; Plante, M.K., 2000:
Pheochromocytoma of the urinary bladder: update on new diagnostic modalities plus case report

Thrasher, J.B.; Rajan, R.R.; Perez, L.M.; Humphrey, P.A.; Anderson, E.E., 1993:
Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options

Sugi, Y.; Muro, A.; Yoshida, T.; Takajyo, Y.; Matsuoka, H.; Ohuchida, M.; Kato, S.; Oka, N.; Honma, T.; Ikeda, H.; Imaizumi, T., 2002:
Pheochromocytoma presenting as acute heart failure

Smith, S.L.; Slappy, A.L.Jackson.; Fox, T.P.; Scolapio, J.S., 2002:
Pheochromocytoma producing vasoactive intestinal peptide

Escobedo Palau, J.A.; Chena Alejandro, J.A.; Rubio Félix, S.A.; Aznar Carbonell, A.; Sebastián Royo, B.; Fernández García, A., 1994:
Pheochromocytoma secreting adrenaline, a rare form of presentation

Moulin, C.; Delomez, M.; Bauchart, J.J.; Lesenne, M.; Asseman, P.; Théry, C., 2000:
Pheochromocytoma simulating myocardial infarct. Apropos of a case

Castilho, L.N.; Medeiros, P.J.; Mitre, A.I.; Dénes, F.T.; Lucon, A.M.; Arap, S., 2000:
Pheochromocytoma treated by laparoscopic surgery

Rajaratnam, S.; Seshadri, M.S.; Nair, A.; Shanthly, N.; Srivastava, V., 2001:
Pheochromocytoma with base of skull metastasis

González-Villarón, L.; Santana, S.; Pérez-Arellano, J.L.; Sánchez-Sánchez, R.; Castro del Pozo, S., 1993:
Pheochromocytoma with ectopic secretion of ACTH

Shawar, L.; Svec, F., 1996:
Pheochromocytoma with elevated metanephrines as the only biochemical finding

Chlebus, M.; Lapiński, M.; Torbicki, A.; Chlebus, H.; Szostek, M.; Wocial, B.; Staszkiewicz, W.; Januszewicz, W., 1996:
Pheochromocytoma with hemorrhagic necrosis and rupture with symptoms of acute abdomen and shock

Tamasawa, N.; Terada, A.; Kodama, T.; Ishigame, M.; Ishimaru, K.; Hishida, R.; Satoh, T.; Takebe, K.; Sasaki, M.; Imamura, K., 1994:
Pheochromocytoma with multiple islet cell carcinoma

Banquer, K.J., 1993:
Pheochromocytoma with multiple system failure

Yoshida, K.; Tatsukawa, H.; Ashida, K.; Matsubara, K.; Kubota, Y.; Uwatoko, H.; Ogasawara, H.; Katsuma, Y.; Kitamura, K., 2001:
Pheochromocytoma with severe paralytic ileus occurred from acute pulmonary edema caused by metoclopramide

Simon, J.S..; Evans, D., 1986:
Pheochromocytoma, Depression, and Electroconvulsive Therapy

Favia, G.; Lumachi, F.; Polistina, F.; D'Amico, D.F., 1998:
Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients

Juncal, A.; Figueras, J., 1996:
Pheochromocytoma, acute myocardial infarction and silent postprandial ischemia

Box, J.C.; Braithwaite, M.D.; Duncan, T.; Lucas, G., 1997:
Pheochromocytoma, chronic renal insufficiency, and hemodialysis: a combination leading to a diagnostic and therapeutic dilemma

Gagel, R.F., 1994:
Pheochromocytoma, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

Kauppinen-Mäkelin, R.; Heikkilä, P., 1995:
Pheochromocytoma, pulmonary nodule and hypercalcemia

Brandão, A.; Gomes, A.; Pereira, M.; Brandão, I.; Basto, L.; Delgado, M.; Gonçalves, C.; Lemos, P.; Falcão, J.; Rodrigues, P., 1993:
Pheochromocytoma--apropos a clinical case

Orchard, T.; Grant, C.S.; van Heerden, J.A.; Weaver, A., 1993:
Pheochromocytoma--continuing evolution of surgical therapy

Dluhy, R.G., 2002:
Pheochromocytoma--death of an axiom

Manhem, P.; Wahrenberg, H., 2002:
Pheochromocytoma--rare and often undiagnosed condition

Januszewicz, W.; Wocial, B., 1995:
Pheochromocytoma--the catecholamine dependent hypertension

Dudorkinová, D., 1996:
Pheochromocytoma-ganglioneuroma of the adrenal gland

Vincent, D.; Pradalier, A., 1993:
Pheochromocytoma-like catecholamine levels induced by clonidine cessation

Satani, O.; Katsuragi, M.; Hano, T.; Tomobuchi, Y.; Arita, M.; Nishio, I., 1996:
Pheochromocytoma-related myocardial damage following delivery

Lindstedt, G.; Kågedal, B.; Ahlman, H.; Karlberg, B.E., 1998:
Pheochromocytoma. Methoxycatecholamines in nocturnal urine and chromogranin in EDTA-blood should be measured first

Rabii, R.; Joual, A.; Rais, H.; Bennani, S.; el Mrini, M.; Benjelloun, S., 1999:
Pheochromocytoma. Report of 10 cases

Friberg, P., 1998:
Pheochromocytoma. The risk to miss diagnosis of severe disease is reduced when free metanephrines are measured in plasma

Sharma, N.; Kumari, S.; Jain, S.; Varma, S., 2002:
Pheochromocytoma: a 10-year experience in a tertiary care North Indian hospital

Shargorodsky, M.; Zimlichman, R., 2002:
Pheochromocytoma: a disease with many faces

Blasco Alfonso, J.E.; Donderis Guastavino, C.; Pallas Costa, Y.; Vernich Talens, L.; Navalón Verdejo, P.; Eres Saez, F.J.; Ramada Benlloch, F.J.; Zaragoza Orts, J., 1996:
Pheochromocytoma: a review of our own cases

Bravo, E.L., 2002:
Pheochromocytoma: an approach to antihypertensive management

Ariton, M.; Juan, C.S.; AvRuskin, T.W., 2001:
Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital

Rosenthal, R.; Conen, D., 2000:
Pheochromocytoma: diagnosis and treatment

Young, W.F., 1997:
Pheochromocytoma: issues in diagnosis & treatment

Gross, J.S.; Shua-Haim, J.R., 1996:
Pheochromocytoma: on the verge of extinction under managed care

Dubois, R.; Chappuis, J.P., 1998:
Pheochromocytoma: pediatric features

Shi, J., 1993:
Pheochromocytoma: report of 40 cases

Bogdonoff, D.L., 2002:
Pheochromocytoma: specialist cases that all must be prepared to treat?

Hamdan, A.; Hirsch, D.; Green, P.; Neumann, A.; Drozd, T.; Molad, Y., 2002:
Pheochromocytoma: unusual presentation of a rare disease

Faiçal, S.; Shiota, D., 1997:
Pheochromocytoma: update on diagnosis and treatment

Mignon, F.; Mesurolle, B.; Laplanche, A., 2002 :
Pheochromocytomas and CT: can size predict malignancy?

O'Riordan, J.A., 1998:
Pheochromocytomas and anesthesia

Baghai, M.; Thompson, G.B.; Young, W.F.; Grant, C.S.; Michels, V.V.; van Heerden, J.A., 2002:
Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery

Hoegerle, S.; Nitzsche, E.; Altehoefer, C.; Ghanem, N.; Manz, T.; Brink, I.; Reincke, M.; Moser, E.; Neumann, H.P.H., 2002:
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.

Shulkin, B.L.; Thompson, N.W.; Shapiro, B.; Francis, I.R.; Sisson, J.C., 1999:
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

Ito, Y.; Obara, T.; Yamashita, T.; Kanbe, M.; Iihara, M., 1996:
Pheochromocytomas: tendency to degenerate and cause paroxysmal hypertension

Kurosawa, S.; Takenaka, M.; Dunkelblum, E.; Mendel, Z.; Mori, K., 2002:
Pheromonal and kairomonal activities can be separated: synthesis and bioactivity studies of pine bast scale sex pheromones and their analogues

Wysocki, C.J.; Preti, G., 1999:
Pheromonal influences

Choi, M-Yeon.; Han, K.Sik.; Boo, K.Saeng.; Jurenka, R.A., 2003:
Pheromone biosynthetic pathways in the moths Helicoverpa zea and Helicoverpa assulta

Kaissling, K.E., 1998:
Pheromone deactivation catalyzed by receptor molecules: a quantitative kinetic model

Zufall, F.; Kelliher, K.R.; Leinders-Zufall, T., 2002:
Pheromone detection by mammalian vomeronasal neurons

Beckman, M., 2002:
Pheromone reception. When in doubt, mice mate rather than hate

Wekesa, K.S.; Anholt, R.R., 1997:
Pheromone regulated production of inositol-(1, 4, 5)-trisphosphate in the mammalian vomeronasal organ

Ferreira, J.T.; Zarbin, P.H., 1996:
Pheromone syntheses: a tropical approach. Enantioselective synthesis of the (2R,6S,10S) and (2S,6S,10S) isomers of methyl 2,6,10-trimethyldodecanoate

Greene, M.J.; Stark, S.L.; Mason, R.T., 2002:
Pheromone trailing behavior of the brown tree snake, Boiga irregularis

Leal, W.S.; Wojtasek, H.; Miyazawa, M., 1999:
Pheromone-binding proteins of scarab beetles

Brurberg, M.B.; Nes, I.F.; Eijsink, V.G., 1998:
Pheromone-induced production of antimicrobial peptides in Lactobacillus

Kroner, C.; Breer, H.; Singer, A.G.; O'Connell, R.J., 1996:
Pheromone-induced second messenger signaling in the hamster vomeronasal organ

McClintock, M.K.; Jacob, S.; Zelano, B.; Hayreh, D.J., 2002:
Pheromones and vasanas: the functions of social chemosignals

Christensen, T.A.; Sorensen, P.W., 1996:
Pheromones as tools for olfactory research.Introduction

Cutler, W.B.; Genovese, E., 2002:
Pheromones, sexual attractiveness and quality of life in menopausal women

Johnston, R.E., 1999:
Pheromones, the vomeronasal system, and communication. From hormonal responses to individual recognition

Kamenev; Gefen, 1994:
Phi 0-periodic Aharonov-Bohm oscillations and ensemble averaging

Chen; Moreno; Hernando, 1995:
Phi 0/2 vortices in a defect-containing Josephson-junction array

Blasco, M.A.; Lázaro, J.M.; Blanco, L.; Salas, M., 1993:
Phi 29 DNA polymerase active site. The conserved amino acid motif "Kx3NSxYG" is involved in template-primer binding and dNTP selection

Truniger, V.; Lázaro, J.M.; Salas, M.; Blanco, L., 1998:
Phi 29 DNA polymerase requires the N-terminal domain to bind terminal protein and DNA primer substrates

Marians, K.J., 1995:
Phi X174-type primosomal proteins: purification and assay

Ko; Lévai; Qiu; Li, 1992:
Phi meson in dense matter

Horovitz, A.; Amir, A.; Danziger, O.; Kafri, G., 2002:
Phi value analysis of heterogeneity in pathways of allosteric transitions: Evidence for parallel pathways of ATP-induced conformational changes in a GroEL ring

Meijer, W.J.; Horcajadas, J.A.; Salas, M., 2001:
Phi29 family of phages

Perazzo, C.Alberto.; Mac Intyre, J.R.; Gomba, J.M., 2018:
Analytical solutions for the profile of two-dimensional droplets with finite-length precursor films

Gramm, P., 1981:
Phil Gramm predicts more radical health changes by 1983 or 1984. Interview by Sheila L. Simler

Anonymous, 2001:
Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain

Anonymous, 2001:
Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain

Anonymous, 2001:
Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain

Anonymous, 2001:
Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain

Anonymous, 2001:
Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions: overview and methodology

Droste, T.M., 1997:
Philadelphia academic medical center evolves through a partnering strategy

Shannon, G.W.; Cromley, R.G., 1982:
Philadelphia and the yellow fever epidemic of 1798

Anonymous, 1996:
Philadelphia area AIDS/HIV clinical trials

Daugherty, M.L., 1983:
Philadelphia area hospitals conduct campaign against underfunding

Arican, A.; Ozbek, N.; Baltaci, V.; Haberal, M., 1999:
Philadelphia chromosome (+) T-cell acute lymphoblastic leukaemia after renal transplantation

Arican, A.; Ozbek, N.; Baltaci, V.; Haberal, M., 2000:
Philadelphia chromosome (+) T-cell acute lymphoblastic leukemia after renal transplantation

Nagai, K.; Hayashibara, T.; Imanishi, D.; Honda, S.; Mine, M.; Kuriyama, K.; Asanaga, M., 1997:
Philadelphia chromosome (BCR/ABL)--positive acute lymphoblastic leukemia: clinical characteristics and prognostic analysis for the effective therapeutic strategy

Pajor, L.; Kereskai, L.; Zsdrál, K.; Nagy, Z.; Vass, J.A.; Jáksó, P.; Radványi, G., 2002:
Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation

Knuutila, S.; Lindlöf, M.; Kovanen, P.E.; Ramqvist, T.; Ruutu, T.; Andersson, L.C., 1993:
Philadelphia chromosome as the sole abnormality and p210 bcr-abl chimeric protein expression in an Epstein-Barr virus-transformed B cell line from a patient with chronic myeloid leukemia

Beyermann, B.; Adams, H.P.; Henze, G., 1997:
Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group

Takeuchi, M.; Soda, R.; Takahashi, K.; Kimura, F.; Lai, M.; Ueda, Y., 2000:
Philadelphia chromosome positive acute lymphocytic leukemia arising from aplastic anemia

Saigo, K.; Nakagawa, T.; Ryo, R.; Yamaguchi, N., 1995:
Philadelphia chromosome-negative chronic myelogenous leukemia with trisomy 13

Gladstone, D.E.; Bedi, A.; Miller, C.B.; Noga, S.J.; Griffin, C.A.; Piantadosi, S.; Cagnoni, P.J.; Brodsky, R.A.; Smith, B.D.; Douglas, T.T.; Shpall, E.J.; Jones, R.J., 1999:
Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia

Inokuchi, K.; Dan, K., 2001:
Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia

Schrappe, M.; Aricò, M.; Harbott, J.; Biondi, A.; Zimmermann, M.; Conter, V.; Reiter, A.; Valsecchi, M.G.; Gadner, H.; Basso, G.; Bartram, C.R.; Lampert, F.; Riehm, H.; Masera, G., 1998:
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome

Lestingi, T.M.; Hooberman, A.L., 1993:
Philadelphia chromosome-positive acute lymphoblastic leukemia

Tatsumi, T.; Shimazaki, C.; Araki, S.I.; Sudo, Y.; Yamagata, N.; Ashihara, E.; Goto, H.; Inaba, T.; Fujita, N.; Nakagawa, M.; Misawa, S.I.; Imashuku, S., 1997:
Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for Langerhans cell histiocytosis

Oki, Y.; Kishi, Y.; Kami, M., 2000:
Philadelphia chromosome-positive acute lymphoblastic leukemia in children

Takamatsu, T., 2001:
Philadelphia chromosome-positive acute lymphoblastic leukemia preceded by acute pleuropericarditis

Hatsuse, M.; Shimazaki, C.; Tsubakimoto, Y.; Ochiai, N.; Okano, A.; Ashihara, E.; Inaba, T.; Fujita, N.; Nakagawa, M., 2001:
Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy 7 successfully treated with intermediate- and high-dose ara-C

Faderl, S.; Garcia-Manero, G.; Thomas, D.A.; Kantarjian, H.M., 2002:
Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives

Varma, N.; Varma, S.; Movafagh, A.; Mittal, O.; Garewal, G., 1993:
Philadelphia chromosome-positive chronic myelocytic leukemia with abnormal chromatin clumping (ACC) syndrome

Shea, M.P.; Abshire, T.C., 1993:
Philadelphia chromosome-positive chronic myeloid leukemia and thoracic ganglioneuroma. Previously undescribed association

Ohsaka, A.; Shiina, S.; Kobayashi, M.; Kudo, H.; Kawaguchi, R., 2003:
Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL)

Hernández-Boluda, J.C.; Cervantes, F.; Camós, M.; Costa, D.; Rafel, M.; Montserrat, E., 1999:
Philadelphia chromosome-positive chronic myeloid leukemia in the elderly: presenting features, natural history and survival

Seong, D.; Thall, P.; Kantarjian, H.M.; Talpaz, M.; Swantkowski, J.; Xu, J.; Shen, Y.; Glassman, A.; Ramagli, L.; Siciliano, M.J., 1998:
Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow

Kantrow, L., 1980:
Philadelphia gentry: fertility and family limitation among an American aristocracy

Gilbride, N., 1983:
Philadelphia home health experiencing market boom

Pallarito, K., 1993:
Philadelphia hospital succumbs to its market

Anonymous, 1992:
Philadelphia hospital to feed revolution in patient care

Nemes, J., 1992:
Philadelphia hospital's C-rated debt may go lower

Stiller, J., 1980:
Philadelphia judge rules PSRO not subject to FOIA disclosure requirements

Pallarito, K., 1994:
Philadelphia merger talks go slowly

Mahon, F.X.; Labouyrie, E.; Aurich-Costa, J.; Dastugue, N.; Micheau, M.; Bady, C.; Perel, Y.; Bilhou-Nabera, C.; Reiffers, J.; Bernard, P., 1997:
Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child

Vellupillai, M.; Tan, L.T.; Lau, L.C.; Fook-Chong, S.M.; Lim, L.C., 2000:
Philadelphia positive acute lymphoblastic leukaemia (ALL): clinico-haematologic characteristics, molecular analyses and 3-year follow up--a single institution study

Navarro, J.L.; de Blas Orlando, J.; Ríos Herranz, E.; González Campos, J.; Parody, R.; Rodríguez Fernández, J.M., 1998:
Philadelphia positive acute lymphoblastic leukemia 16 years after the apparent cure of acute lymphoblastic leukemia. New leukemia or late relapse?

Perry, L., 1989:
Philadelphia providers' ship comes in with Navy families

Lear, W.J., 1980:
Philadelphia sans PGH

Pallarito, K., 1995:
Philadelphia systems' merger gets nod from rating agency

Van Wyck Good, W.; Mitchell, S.W., 1993:
Philadelphia's "literary physician": the papers of S. Weir Mitchell

Shanske, A.L.; Grunwald, H.; Cook, P.; Heisterkamp, N.; Groffen, J., 1998:
Philadelphia-negative chronic myelogenous leukemia in a patient with a unique complex translocation: 46,XY,t(9;12;15)(q34;12;q21)

Pérez-Losada, J.; Gutiérrez-Cianca, N.; Sánchez-García, I., 2001:
Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell

Zámecníková, A.; Gyárfás, J.; Krizan, P.; Weismanová, E., 1996:
Philadelphia-positive chronic myeloid leukemia with del(7)(p11p15)

Cerne, F., 1994:
Philadelphia. Blues plan links its future with a provider network

Boyd-Monk, H., 1996:
Philanthropic Societies

Karamash, S.; Bykhovsky, G., 1996:
Philanthropic activity of Doctor G. Bykhovsky

Pallarito, K., 1999:
Philanthropic confusion. Hospitals now pitch community need, not their own

Rudney, G.; Weitzman, M., 1984:
Philanthropic employment growth from 1972 to 1982

Murden, R.A.; Lamb, J.F., 1999:
Philanthropic endowments in general internal medicine

Lutz, S., 1992:
Philanthropic support is built into the design of some projects

Coury, J.M., 1999:
Philanthropic volunteer service for the public good: hospice volunteers in the United States of America

Pallarito, K., 1994:
Philanthropies take closer look at grant requests

Anonymous, 2002:
Philanthropist or commercial opportunist?

Ageeva, Z.M., 1998:
Philanthropists and psychiatry in Moscow

Smith, W.L., 1996:
Philanthropy

Sherman, A.; Brockman, S.S., 1981:
Philanthropy -- getting your piece of the pie. How to set up a hospital development program implemented by a nonprofit foundation

Smith, D.G.; Clement, J.P.; Wheeler, J.R., 1995:
Philanthropy and hospital financing

Kohler, R.E., 1985:
Philanthropy and science

Anonymous, 1993:
Philanthropy and the '91 recession

Sloane, R.M., 1983:
Philanthropy and the hospital. Interview by Robert L. Davis

DeLauro, J.P., 1997:
Philanthropy and the identity crisis in health care

Dymowski, V.G., 1991:
Philanthropy and the nonprofit hospital

Karl, B.D., 1984:
Philanthropy and the social sciences

Harriss, C.L., 1976:
Philanthropy and the tax expenditure concept

Smith, S.R., 1983:
Philanthropy can play important role in hospital finances

Haussler, P.H., 1982:
Philanthropy for patient care

Littman, C.A., 1982:
Philanthropy from the donor's perspective

Murphy, J., 1985:
Philanthropy in the 80s: changing priorities and targeted giving

Gerber, R.J., 1994:
Philanthropy update

Bond, E.; Peck, M.; Hede, K., 1999:
Philanthropy with modest means

Porter, M.E.; Kramer, M.R., 2000:
Philanthropy's new agenda: creating value

Solovy, A., 1989:
Philanthropy's new thrust

Glabman, M., 1997:
Philanthropy. An uncharitable analysis

Kaiser, J., 2001:
Philanthropy. Caltech lands record-breaking $600 million

Brandt, R., 2001:
Philanthropy. Gates gives booster shot to AIDS vaccines

Anonymous, 1997:
Philanthropy. How unbearably nice

Pokrovsky, V.; Allakhverdov, A.; Astvatsaturyan, M., 2001:
Philanthropy. Russian billionaires launch science fund

Brockman, S., 1985:
Philanthropy. This traditional source of capital financing is becoming more critical

Dellandrea, J.S.; Koblin, H.A., 1999:
Philanthropy: a key ingredient of institutional change

Campbell, D.A., 1985:
Philanthropy: shareholders and capital formation for hospitals

Hobbie, W.F., 1995:
Philanthropy: the key to health care health

Young, M.T., 1975:
Philanthropy: the key to solving pressing financial problems

Shafrir, E., 1997:
Philatelic history of diabetes

O'Rahilly, R., 1997:
Philatelic introduction to the history of anatomy

Onat, T., 2001:
Philatelic list of persons and their contributions to genetics

Shubich, I., 2002:
Philately and otolaryngology

Reed, R.V.; Traynor, P.A., 1996:
Philip Andrew Traynor, DDS, FACD, (1874-1962)

Matthews, L.G.; Guide, P., 1975:
Philip Guide, Huguenot refugee doctor of medicine (ca.1640-1716)

Smith, E.L.; Hill, R.L.; Handerl, P., 1985:
Philip Handler: August 13, 1917 - December 29, 1981

Koerner, B.I., 2000:
Philip Kennedy. Melding man and machine to free the paralyzed

Downey, L.A.; Brown, P.K., 1985:
Philip King Brown and the Arequipa Sanatorium

Lee, P.R., 1994:
Philip Lee, M.D. Health and Human Services Assistant Secretary. Interview by Renee Blankenau

Clarke, C.; Sheppard, P.M., 1977:
Philip Macdonald Sheppard, 27 July 1921--17 October 1976

Meynell, G.; Miller, P., 1987:
Philip Miller's resignation from the Chelsea physic garden

Myers, M.L., 2002:
Philip Morris changes its name, but not its harmful practices

Anonymous, 1996:
Philip Morris cigarettes recall, May 1995-March 1996. From the Centers for Disease Control and Prevention

Simpson, D., 1997:
Philip Morris goes nuts in Brazil

Skolnick, A.A., 1993:
Philip Morris recalls Marlboro cigarette lighter, considered 'enticing fire hazard for children'

Hirschhorn, N.; Bialous, S.A.; Shatenstein, S., 2001:
Philip Morris' new scientific initiative: an analysis

Erde, E.L., 1995:
Philip Roth's Patrimony: narrative and ethics in a case study

Brady, L.W.; Sagerman, R.; Rubin, P., 1997:
Philip Rubin

Shampo, M.A.; Kyle, R.A.; Hench, P.S., 2001:
Philip S. Hench--1950 Nobel laureate

Wilhelmson, B.; Sandblom, P., 1994:
Philip Sandblom: artist of medicine, analyzer of art. Pain gives depth and dimension to life

Chase, H.V.; Thomas, P., 1999:
Philip Thomas (1747-1815) physician, patriot, politician

SoRelle, R.; Majerus, P.W., 1998:
Philip W. Majerus, MD: Bristol-Myers Squibb Award

Vines, 1999:
Philip cohen: playing to win

Bewley; Lock, 1998:
Philip henry connell

Chakravorty, R.C.; von Siebold, P.F., 1996:
Philipp Franz von Sebold

Thomas, U.; Geiger, P.L.; Liebig, J.v., 1988:
Philipp Lorenz Geiger and Justus Liebig

Anonymous, 1981:
Philipp v. Carey

Weatherford, R.; Foot, P., 1979:
Philippa Foot and the doctrine of double effect

Mitchell, A.; Ariès, P., 1978:
Philippe Ariès and the French way of death

Spagnoli, P.G.; Ariès, P., 1981:
Philippe Ariès, historian of the family

Berrios, G.E.; Fuentenebro, F.; Chaslin, P.; Chaslin, P., 1995:
Philippe Chaslin and descriptive psychopathology. Is 'psychiatry' a well made language?

Golvers, N.; Couplet, P., 2000:
Philippe Couplet, S.J. (1623-1693) and the authorship of Specimen Medicinae Sinensis and some other western writings on Chinese medicine

Postel, J.; Farjon, E.; Decourt, P., 1991:
Philippe Decourt (1902-1990) and the discovery of psychoactive effects of chlorpromazine

Iselin, F.; Detrie, P., 1996:
Philippe Detrie 1921-1996

Chiron, J.P.; Coursaget, P.; Yvonnet, B.; Maupas, P., 2001:
Philippe Maupas : hepatitis B vaccine discoverer

Kohl, F., 1996:
Philippe Pinel and the legendary "chain liberation" in the Bicêtre (1793) and Salpêtrìere (1793) Paris hospitals. I: Pinel's personality and previous reform attempts

Kohl, F.; Pinel, P., 1996:
Philippe Pinel and the legendary "unchaining" at the Paris Bicêtre (1793) and Salpêtrière (1795) Hospitals. II: Historical background, allegorical descriptions discipline generated myths

Caire, M.; Pinel, P., 1995:
Philippe Pinel in 1784. A "foreign" physician in front of the Paris Faculty of Medicine

Weiner, D.B.; Pinel, P., 1991:
Philippe Pinel, professor of medical physics, according to newly discovered documents

Macchi, A.; Tagliabue, A.; Levrini, L.; Trezzi, G., 2002:
Philippe self-ligating lingual brackets

Henderickx, L.; Schmerling, P.C., 1994:
Philippe-Charles Schmerling (1790-1836) reveals the antiquity of man thanks to antediluvian deposits of the Liège caves

Trépardoux, F.; Pia, P.N., 1997:
Philippe-Nicolas Pia (1721-1799), alderman of Paris, pioneer of first aid for drowning victims (first part)

Trépardoux, F.; Pia, P.N., 1997:
Philippe-Nicolas Pia (1721-1799), creator of the first-aid service to rescue drowned people

Ulack, R., 1979:
Philippine Muslim population change, 1960 to 1970

Rodriguez Ar, 1995:
Philippine National AIDS Council

Manuel-santana, R., 1993:
Philippine campaign boosts child immunizations

Herrin, A.N., 1982:
Philippine demographic development: problems and prospects

Ancog, A.C., 1992:
Philippine law on donations of human organs

Anonymous, 1992:
Philippine laws and policies on the status of women

Anonymous, 1974:
Philippine laws, regulations back policy to contain population growth

Battistella, G., 2002:
Philippine migration policy: dilemmas of a crisis

Mejia Tryti, M.R., 1993:
Philippine nursing education is more comprehensive than the Norwegian one